Asia-Pacific Pharmaceutical (002370.SZ): The consistency evaluation of spironolactone tablets has been accepted.

Zhijing Finance APP News, Asia Pacific Pharmaceuticals (002370.SZ) announced that the company recently received the acceptance notification from the National Medical Products Administration regarding the consistency evaluation of spironolactone tablets. Spironolactone tablets are used for edematous diseases, hypertension, primary aldosteronism, and prevention of hypokalemia.